2016; Yin et al. 2016; Zhang et al. 2016; Yao et al. 2017). As we know, ALDP and DST are often simultaneously used for treating coronary heart disease in clinic in China. However, it is unknown whether there is an interaction between ALDP and DST. A better understanding of the pharmacokinetic interaction between DST and ALDP would help facilitate the design of rational dosage regimens and avoiding the occurrence of adverse reactions (Yang et al. 2011). This evidence concerns the gene ABCD1 and coronary artery disorder.